Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,304 warrant series at 1,050 companies. 774 in the money, 59 expiring in the next 30 days, 36 waiting on a stockholder vote or other stated condition, 0 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class D Warrants (June 2026 inducement) | $0.7510 | $401K | 424B5, Aug 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| Initial Warrants (October 2026 Senior Convertible Note financing, First Tranche) | $0.7510 | $401K | 424B3, Oct 21, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January 2026 Representative (Placement Agent) Warrants | $0.7510 | $401K | 424B5, Aug 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| May 2026 Representative (Placement Agent) Warrants | $0.7510 | $401K | 424B5, Aug 5, 2026Dilution tabAs of Nov 16, 2026 | ||||||||
| January–February 2025 convertible note unit warrants — 55,000 shares at $0.01, expiring 2029-12-31 | $0.0021 | $399K | 10-K, Mar 24, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| November 2023 consultant common stock purchase option — 500,000 shares at $0.01 | $0.0021 | $399K | 10-K, Mar 24, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| November–December 2024 convertible note unit warrants — 70,000 shares at $0.01, expiring 2029-12-31 | $0.0021 | $399K | 10-K, Mar 24, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| September 19, 2018 promissory note lender warrants — 2,000 shares at a 15% discount to market | $0.0021 | $399K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 27, 2026 | ||||||||
| December 2024 Common Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| February 2024 Series A Common Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| February 2025 Common Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| February 2025 Pre-funded Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| January 2025 Common Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Private Placement Warrants (PBAX IPO) | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Public Warrants (PBAX IPO) | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| September 2024 Series C Common Warrants | $0.0046 | $392K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2023 Rights Offering Warrants ($1.25) | $0.0092 | $333K | 424B3, Mar 2, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 Convertible Note warrants (October 8, 2024, $9.20) | $0.0092 | $333K | 10-K, Apr 1, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 11, 2025 note purchase agreement warrants ($18.40) | $0.0092 | $333K | S-1/A, Feb 24, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| June 2025 debt-refinancing warrants ($17.25, two accredited investors) | $0.0092 | $333K | S-1/A, Feb 24, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 OID convertible note warrants ($11.50) – EROP Enterprises portion | $0.0092 | $333K | 424B3, Sep 22, 2025Dilution tabAs of Nov 14, 2026 | ||||||||
| Merger Warrants (Amaze Software acquisition, March 7, 2025) | $0.0092 | $333K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Oak Ridge placement agent warrants (Series B Preferred offering, 2024) | $0.0092 | $333K | S-1/A, Feb 24, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Second A&R Note Warrant (Thomas Frame, August 11, 2025) | $0.0092 | $333K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series C Preferred investor warrants (100% coverage, March–May 2025) | $0.0092 | $333K | S-1/A, Feb 24, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Private Placement Warrants (Dune Acquisition Corporation) | $0.0444 | $332K | 10-Q, Aug 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Public Warrants (Dune Acquisition Corporation IPO warrants, HGASW) | $0.0444 | $332K | 10-Q, Aug 13, 2026Dilution tabAs of Nov 4, 2026 | ||||||||
| Consultant warrants issued in fiscal year ended September 30, 2025 — 2,000,000 shares at $0.02 | $0.0018 | $328K | 10-K, Jan 15, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Regulation A Series D Unit warrants sold in fiscal year ended September 30, 2025 — 390,250 shares at $0.30 | $0.0018 | $328K | 10-K, Jan 15, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Regulation A Series D Unit warrants sold in the nine months ended June 30, 2026 — 310,063 shares at $0.30 | $0.0018 | $328K | 10-Q, Aug 14, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Residual legacy warrants outstanding at September 30, 2023 not broken out by series — 1,500,000 shares | $0.0018 | $328K | 10-K, Jan 15, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Warrants issued October 1, 2022 in connection with modification of the $200,000 senior secured convertible note (Note 7(2)) — 4,621,105 shares | $0.0018 | $328K | 10-Q, Aug 14, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Warrants issued October 1, 2022 in connection with modification of the $350,000 senior secured convertible note (Note 7(3)) — 4,550,000 shares | $0.0018 | $328K | 10-Q, Aug 14, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Warrants issued October 1, 2022 in connection with the $362,765 senior secured convertible note (Note 7(4)) — 4,715,945 shares | $0.0018 | $328K | 10-Q, Aug 14, 2026Dilution tabAs of Sep 12, 2026 | ||||||||
| Common stock warrants (aggregate per antidilutive-securities footnote) | $0.00010 | $300K | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| $0.0005 price-protected warrants (post-ratchet aggregate, 2023–2025 convertible-note warrants) | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2023 Warrants (issued with 2023 Convertible Notes) — $0.345 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2024 Warrants (issued with 2024 Convertible Notes) — $0.345 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2025 Warrants — prior-year $0.01 tranche repriced to $0.005 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2026 Warrants — five-year, $0.01 (issued after the April 29, 2026 triggering event) | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2026 Warrants — five-year, originally $0.01, repriced to $0.005 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2026 Warrants — three-year, originally $0.02, repriced to $0.005 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| December 14, 2023 maturity-extension warrants — $0.345 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| July 16, 2026 convertible-note warrant — $0.01 (post-anchor issuance) | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| Legacy $0.4500 warrants (origin not identified in corpus) | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| Legacy $1.5000 warrants (origin not identified in corpus) | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| March 14, 2024 maturity-extension warrants — $0.345 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| May 4, 2024 maturity-extension warrants — $0.345 | $0.00030 | $298K | 10-Q, Aug 14, 2026Dilution tabAs of Aug 16, 2026 | ||||||||
| 2022 Placement Agent Warrants (H.C. Wainwright, November 2022 registered direct) | $0.3200 | $296K | 424B3, Sep 21, 2023Dilution tabAs of Oct 14, 2026 | ||||||||
| Private Placement Warrants | $0.1688 | $280K | 10-K, Apr 15, 2026Dilution tabAs of Nov 16, 2026 |
RUBIRubico Inc. Common Stock$0.7510Last price
Class D Warrants (June 2026 inducement)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$401K
RUBIRubico Inc. Common Stock$0.7510Last price
Initial Warrants (October 2026 Senior Convertible Note financing, First Tranche)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$401K
RUBIRubico Inc. Common Stock$0.7510Last price
January 2026 Representative (Placement Agent) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$401K
RUBIRubico Inc. Common Stock$0.7510Last price
May 2026 Representative (Placement Agent) Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$401K
CPWROcean Thermal Energy Corporation$0.0021Last price
January–February 2025 convertible note unit warrants — 55,000 shares at $0.01, expiring 2029-12-31
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$399K
CPWROcean Thermal Energy Corporation$0.0021Last price
November 2023 consultant common stock purchase option — 500,000 shares at $0.01
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$399K
CPWROcean Thermal Energy Corporation$0.0021Last price
November–December 2024 convertible note unit warrants — 70,000 shares at $0.01, expiring 2029-12-31
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$399K
CPWROcean Thermal Energy Corporation$0.0021Last price
September 19, 2018 promissory note lender warrants — 2,000 shares at a 15% discount to market
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$399K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
December 2024 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
February 2024 Series A Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
February 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
February 2025 Pre-funded Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
January 2025 Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
Private Placement Warrants (PBAX IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
Public Warrants (PBAX IPO)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
CEROCERo Therapeutics Holdings, Inc.$0.0046Last price
September 2024 Series C Common Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$392K
AMZEAmaze Holdings, Inc.$0.0092Last price
2023 Rights Offering Warrants ($1.25)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
2024 Convertible Note warrants (October 8, 2024, $9.20)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
June 11, 2025 note purchase agreement warrants ($18.40)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
June 2025 debt-refinancing warrants ($17.25, two accredited investors)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
May 2025 OID convertible note warrants ($11.50) – EROP Enterprises portion
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
Merger Warrants (Amaze Software acquisition, March 7, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
Oak Ridge placement agent warrants (Series B Preferred offering, 2024)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
Second A&R Note Warrant (Thomas Frame, August 11, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
AMZEAmaze Holdings, Inc.$0.0092Last price
Series C Preferred investor warrants (100% coverage, March–May 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$333K
HGASGlobal Gas Corporation$0.0444Last price
Private Placement Warrants (Dune Acquisition Corporation)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$332K
HGASGlobal Gas Corporation$0.0444Last price
Public Warrants (Dune Acquisition Corporation IPO warrants, HGASW)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$332K
FUNIHypha Labs, Inc.$0.0018Last price
Consultant warrants issued in fiscal year ended September 30, 2025 — 2,000,000 shares at $0.02
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Regulation A Series D Unit warrants sold in fiscal year ended September 30, 2025 — 390,250 shares at $0.30
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Regulation A Series D Unit warrants sold in the nine months ended June 30, 2026 — 310,063 shares at $0.30
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Residual legacy warrants outstanding at September 30, 2023 not broken out by series — 1,500,000 shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Warrants issued October 1, 2022 in connection with modification of the $200,000 senior secured convertible note (Note 7(2)) — 4,621,105 shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Warrants issued October 1, 2022 in connection with modification of the $350,000 senior secured convertible note (Note 7(3)) — 4,550,000 shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
FUNIHypha Labs, Inc.$0.0018Last price
Warrants issued October 1, 2022 in connection with the $362,765 senior secured convertible note (Note 7(4)) — 4,715,945 shares
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$328K
STEKStemtech Corporation$0.00010Last price
Common stock warrants (aggregate per antidilutive-securities footnote)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$300K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
$0.0005 price-protected warrants (post-ratchet aggregate, 2023–2025 convertible-note warrants)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2023 Warrants (issued with 2023 Convertible Notes) — $0.345
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2024 Warrants (issued with 2024 Convertible Notes) — $0.345
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2025 Warrants — prior-year $0.01 tranche repriced to $0.005
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2026 Warrants — five-year, $0.01 (issued after the April 29, 2026 triggering event)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2026 Warrants — five-year, originally $0.01, repriced to $0.005
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
2026 Warrants — three-year, originally $0.02, repriced to $0.005
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
December 14, 2023 maturity-extension warrants — $0.345
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
July 16, 2026 convertible-note warrant — $0.01 (post-anchor issuance)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
Legacy $0.4500 warrants (origin not identified in corpus)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
Legacy $1.5000 warrants (origin not identified in corpus)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
March 14, 2024 maturity-extension warrants — $0.345
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
IPSIInnovative Payment Solutions, Inc.$0.00030Last price
May 4, 2024 maturity-extension warrants — $0.345
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$298K
FEEDENvue Medical, Inc.$0.3200Last price
2022 Placement Agent Warrants (H.C. Wainwright, November 2022 registered direct)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$296K
FOXOFOXO Technologies Inc.$0.1688Last price
Private Placement Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$280K
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,058 dilution snapshots. 4,847 of 5,304 series state an exercise price and 3,367 an expiry date. 83 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.